A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220C. (2019)
Attributed to:
Alignment of Synthesis, Medicinal Chemistry and Structural Genomics to Accelerate UK Drug Discovery: Network SMS-Drug
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.4155/fmc-2019-0181
PubMed Identifier: 31633398
Publication URI: http://europepmc.org/abstract/MED/31633398
Type: Journal Article/Review
Volume: 11
Parent Publication: Future medicinal chemistry
Issue: 19
ISSN: 1756-8919